InvestorsHub Logo
Followers 31
Posts 1639
Boards Moderated 0
Alias Born 03/09/2011

Re: TalShu post# 392115

Saturday, 10/29/2022 5:25:12 PM

Saturday, October 29, 2022 5:25:12 PM

Post# of 426486
Hello TalShu,
Please reread his statement.

Specifically, Amarin's marketing authorization submissions for VASCEPA/VAZKEPA have been achieved in Hong Kong, Saudi Arabia, and Bahrain, and applications remain pending in a number of other markets, including Australia and New Zealand, which are continuing to advance their local procedures.


He is talking about the marketing authorization submissions have been accepted by these countries.
I do not know all the specifics for "approval" but most of the countries require an intention to submit, presubmission meetings, submission of the application, validation of the application, then the assessment of the submitted application followed by a decision from the respective country.
I didn't believe KM was deceiving shareholders in any way. He basically is saying our application have been successfully submitted in these countries and is actively traveling down the paths for approval or rejection whereas we are still in the process of having our applications successfully submitted and validated in other markets such as Australia and New Zealand.
I was pleasantly surprised with cash burn this quarter. I expected a dip in revenue but did not expect that we would still be north of 300m with cash after Q3.
UK sounds promising and they appear to be making strides ahead of what their models have shown.
Have a great weekend.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News